These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34848794)

  • 21. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
    Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetics of type I interferon in systemic lupus erythematosus.
    Bronson PG; Chaivorapol C; Ortmann W; Behrens TW; Graham RR
    Curr Opin Immunol; 2012 Oct; 24(5):530-7. PubMed ID: 22889593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE.
    Gómez-Bañuelos E; Goldman DW; Andrade V; Darrah E; Petri M; Andrade F
    Cell Rep Med; 2024 May; 5(5):101569. PubMed ID: 38744279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
    Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
    Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence analysis of TMEM173 exon 5 in patients with systemic autoimmune diseases.
    Balada E; Selva-O'Callaghan A; Felip L; Ordi-Ros J; Simeón-Aznar CP; Solans-Laqué R; Vilardell-Tarrés M
    Autoimmunity; 2016; 49(1):12-6. PubMed ID: 26593864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.
    Zhu H; Mi W; Luo H; Chen T; Liu S; Raman I; Zuo X; Li QZ
    Arthritis Res Ther; 2016 Jul; 18():162. PubMed ID: 27412348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleic Acid-Sensing and Interferon-Inducible Pathways Show Differential Methylation in MZ Twins Discordant for Lupus and Overexpression in Independent Lupus Samples: Implications for Pathogenic Mechanism and Drug Targeting.
    Marion MC; Ramos PS; Bachali P; Labonte AC; Zimmerman KD; Ainsworth HC; Heuer SE; Robl RD; Catalina MD; Kelly JA; Howard TD; Lipsky PE; Grammer AC; Langefeld CD
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting of type I interferon in systemic autoimmune diseases.
    Crow MK; Olferiev M; Kirou KA
    Transl Res; 2015 Feb; 165(2):296-305. PubMed ID: 25468480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Lesional Juvenile Myositis and Lupus Skin Reveals Overlapping Yet Unique Disease Pathophysiology.
    Turnier JL; Pachman LM; Lowe L; Tsoi LC; Elhaj S; Menon R; Amoruso MC; Morgan GA; Gudjonsson JE; Berthier CC; Kahlenberg JM
    Arthritis Rheumatol; 2021 Jun; 73(6):1062-1072. PubMed ID: 33305541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
    Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
    Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of LncRNA Linc00513 Containing Lupus-Associated Genetic Variants as a Novel Regulator of Interferon Signaling Pathway.
    Xue Z; Cui C; Liao Z; Xia S; Zhang P; Qin J; Guo Q; Chen S; Fu Q; Yin Z; Ye Z; Tang Y; Shen N
    Front Immunol; 2018; 9():2967. PubMed ID: 30619325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies.
    Ekholm L; Vosslamber S; Tjärnlund A; de Jong TD; Betteridge Z; McHugh N; Plestilova L; Klein M; Padyukov L; Voskuyl AE; Bultink IE; Michiel Pegtel D; Mavragani CP; Crow MK; Vencovsky J; Lundberg IE; Verweij CL
    Scand J Immunol; 2016 Aug; 84(2):100-9. PubMed ID: 27173897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis.
    Liao AP; Salajegheh M; Nazareno R; Kagan JC; Jubin RG; Greenberg SA
    Ann Rheum Dis; 2011 May; 70(5):831-6. PubMed ID: 21177291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.